Sonali Aansh Industries Limited (DSE:SONALIANSH)

Verve Therapeutics Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2,134	2,853	2,509	1,221	1,189	972
Market Cap Growth	-36.90%	13.73%	105.51%	2.69%	22.33%	-31.64%
Enterprise Value	3,203	3,898	3,469	2,125	2,052	1,905
Last Close Price	196.70	261.88	229.90	111.87	108.69	88.62
PE Ratio	305.91	81.40	119.92	114.74	388.57	581.74
PS Ratio	1.53	3.61	5.42	2.04	2.35	2.14
PB Ratio	2.93	4.26	3.92	1.97	1.94	1.59
P/TBV Ratio	3.18	4.64	4.29	2.17	2.14	1.75
P/FCF Ratio	27.89	34.89	718.48	74.28	-	-
P/OCF Ratio	104.78	34.12	27.31	47.42	-	76.32
EV/Sales Ratio	2.30	4.94	7.49	3.54	4.05	4.20
EV/EBITDA Ratio	37.36	37.38	227.37	-	561.42	28.99
EV/EBIT Ratio	50.86	44.60	553.49	-	-	33.70
EV/FCF Ratio	41.87	47.67	993.47	129.30	-	-
Debt / Equity Ratio	1.52	1.27	1.48	1.51	1.57	1.48
Debt / EBITDA Ratio	12.92	8.17	62.28	-	263.46	13.79
Debt / FCF Ratio	14.49	10.41	272.11	57.11	-	-
Asset Turnover	0.69	0.46	0.26	0.33	0.28	0.26
Inventory Turnover	2.47	2.61	1.10	0.91	0.67	0.58
Quick Ratio	0.72	1.03	0.95	0.29	0.20	0.15
Current Ratio	1.63	1.83	1.50	1.51	1.48	1.09
Return on Equity (ROE)	0.96%	5.35%	3.32%	1.73%	0.50%	0.27%
Return on Assets (ROA)	1.95%	3.19%	0.22%	-0.43%	-0.21%	2.04%
Return on Capital (ROIC)	2.15%	3.51%	0.25%	-0.50%	-0.24%	2.56%
Return on Capital Employed (ROCE)	5.10%	7.60%	0.60%	-	-	7.50%
Earnings Yield	0.33%	1.23%	0.83%	0.87%	0.26%	0.17%
FCF Yield	3.59%	2.87%	0.14%	1.35%	-3.61%	-0.76%
Dividend Yield	0.51%	0.38%	0.22%	-	0.23%	0.28%
Payout Ratio	200.33%	-	1.50%	19.58%	90.61%	182.43%
Buyback Yield / Dilution	0.14%	-	0.07%	-0.07%	-	-
Total Shareholder Return	0.65%	0.38%	0.29%	-0.07%	0.23%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.